Showing results (311-320 of 486) with videos related to
Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast CancerGiulia Petroni, Aitziber Buqué, Takahiro Yamazaki, et al.Methods in Cell Biology|March 31, 2021
MPA/DMBA-driven mammary carcinomasAitziber Buqué, Maria Perez-Lanzón, Giulia Petroni, et al.Cell Death & Disease|November 27, 2020
Detection of immunogenic cell death and its relevance for cancer therapyJitka Fucikova, Oliver Kepp, Lenka Kasikova, et al.Cell Cycle (Georgetown, Tex.)|November 11, 2009
Disruption of the PP1/GADD34 complex induces calreticulin exposureOliver Kepp, Lorenzo Galluzzi, Fabrizio Giordanetto, et al.Cell Cycle (Georgetown, Tex.)|April 4, 2009
p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosisLaura Senovilla, Ilio Vitale, Lorenzo Galluzzi, et al.Oncoimmunology|August 31, 2012
Trial Watch: Experimental Toll-like receptor agonists for cancer therapyLorenzo Galluzzi, Erika Vacchelli, Alexander Eggermont, et al.Oncoimmunology|May 6, 2015
Trial Watch: Radioimmunotherapy for oncological indicationsNorma Bloy, Jonathan Pol, Gwenola Manic, et al.Oncoimmunology|November 20, 2012
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapyErika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont, et al.Cell Cycle (Georgetown, Tex.)|September 27, 2008
Mutant p53 protein localized in the cytoplasm inhibits autophagyEugenia Morselli, Ezgi Tasdemir, Maria Chiara Maiuri, et al.Annals of the New York Academy of Sciences|October 21, 2010
Surface-exposed calreticulin in the interaction between dying cells and phagocytesIsabelle Martins, Oliver Kepp, Lorenzo Galluzzi, et al.Pageof 49